Immix Biopharma (IMMX) announced that it has received a strategic investment from Goose Capital and former Tanox, Inc. CEO Nancy Chang, Goose founding member. At Tanox, Chang and her team invented and developed FDA-approved Xolair for severe asthma, Trogarzo for HIV, and Ebglyss for dermatitis, collectively generating drug sales exceeding $5B dollars so far.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMMX: